<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37078358</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2831-090X</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Biomolecules &amp; biomedicine</Title><ISOAbbreviation>Biomol Biomed</ISOAbbreviation></Journal><ArticleTitle>The effects of SCARB2 and SELPLG gene polymorphisms on EV71 infection in hand, foot and mouth disease.</ArticleTitle><Pagination><StartPage>815</StartPage><EndPage>824</EndPage><MedlinePgn>815-824</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.17305/bb.2023.8948</ELocationID><Abstract><AbstractText>The same viral infection in different hosts may result in varying levels of clinical symptoms, which is related to the genetic background of the host itself. A total of 406 common cases and 452 severe cases of enterovirus 71 (EV71) infection in Yunnan Province were selected as the research subjects, and SNaPshot technology was used to detect genetic polymorphisms for 25 Tag single-nucleotide polymorphisms (TagSNPs) in the selectin P ligand (SELPLG) and scavenger receptor class B member 2 (SCARB2) genes. Our results demonstrate that SCARB2 polymorphisms (rs74719289, rs3733255 and rs17001551) are related to the severity of EV71 infection (A vs G: OR 0.330; 95% CI 0.115 - 0.947; T vs C: OR 0.336; 95% CI 0.118 - 0.958; and A vs G: OR 0.378; 95% CI 0.145 - 0.984). The SELPLG polymorphisms were not significantly different between common cases and severe cases. Therefore, we conclude that the SCARB2 gene has a protective effect on the course of hand, foot and mouth disease caused by EV71 infection and that SCARB2 gene mutations can reduce the severity of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Feng Yuan</ForeName><Initials>FY</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Medical Genetics, Kunming Medical University, Kunming, China; Kunming Kingmed Institute for Clinical Laboratory Co., Ltd., Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Zeng-Qing</ForeName><Initials>ZQ</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Kunming Children's Hospital, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Laboratory, Yan'an Hospital of Kunming City, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Medical Genetics, Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Li-Jiang</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Infectious Disease Department, Kunming Children's Hospital, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Medical Genetics, Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yantuanjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Medical Genetics, Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yu-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Medical Genetics, Kunming Medical University, Kunming, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Bosnia and Herzegovina</Country><MedlineTA>Biomol Biomed</MedlineTA><NlmUniqueID>9918522188506676</NlmUniqueID><ISSNLinking>2831-0896</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of interest: Authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>20</Day><Hour>5</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37078358</ArticleId><ArticleId IdType="pmc">PMC10494856</ArticleId><ArticleId IdType="doi">10.17305/bb.2023.8948</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Saguil A, Kane SF, Lauters R, Mercado MG. Hand-foot-and-mouth disease: rapid evidence review. Am Fam Physician. 2019;100(7):408–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31573162</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S, Arunkumar G, Alidjinou EK, Hober D. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol. 2016;205(5):397–407. https://doi.org/10.1007/s00430-016-0465-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventarola D, Bordone L, Silverberg N. Update on hand-foot-and-mouth disease. Clin Dermatol. 2015;33(3):340–6. https://doi.org/10.1016/j.clindermatol.2014.12.011.</Citation><ArticleIdList><ArticleId IdType="pubmed">25889136</ArticleId></ArticleIdList></Reference><Reference><Citation>De W, Changwen K, Wei L, Monagin C, Jin Y, Cong M, et al. A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guangdong, China, 2009. Arch Virol. 2011;156(6):945–53. https://doi.org/10.1007/s00705-011-0929-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21305327</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao YW, Ho BC, Chen MH, Yu SL. Enterovirus 71 infection shapes host T cell receptor repertoire and presumably expands VP1-specific TCRβ CDR3 cluster. Pathogens. 2020;9(2):121. https://doi.org/10.3390/pathogens9020121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169398</ArticleId><ArticleId IdType="pubmed">32075096</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, et al. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci USA. 2013;110(36):14753–8. https://doi.org/10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Ong KC, Gao Z, Zhao X, Anderson VM, McNutt MA, et al. Tonsillar crypt epithelium is an important extra-central nervous system site for viral replication in EV71 encephalomyelitis. Am J Pathol. 2014;184(3):714–20. https://doi.org/10.1016/j.ajpath.2013.11.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">24378407</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskelinen E L, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13(3):137–45. https://doi.org/10.1016/S0962-8924(03)00005-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12628346</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yang P, Wang N, Zhang J, Li J, Guo H, et al. The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection. Protein Cell. 2017;8(8):590–600. https://doi.org/10.1007/s13238-017-0405-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546930</ArticleId><ArticleId IdType="pubmed">28447294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-W, Lin H-Y, Tsou Y-L, Chitra E, Hsiao K-N, Shao H-Y, et al. Human SCARB2-mediated entry and endocytosis of EV71. PLoS One. 2012;7(1):e30507. https://doi.org/10.1371/journal.pone.0030507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Sudaka Y, Takashino A, Kobayashi K, Kataoka C, Suzuki T, et al. VP.amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection. J Virol. 2018;92(15):e00682–18. https://doi.org/10.1128/JVI.00682-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinoco R, Otero DC, Takahashi AA, Bradley LM, et al. PSGL-1: a new player in the immune checkpoint landscape. Trends Immunol. 2017;38(5):323–35. https://doi.org/10.1016/j.it.2017.02.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5411281</ArticleId><ArticleId IdType="pubmed">28262471</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794–7. https://doi.org/10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Zou Q, Chen L, Zhang H, Wang Y. Molecular analysis of virulent determinants of enterovirus 71. PLoS One. 2011;6(10):e26237. https://doi.org/10.1371/journal.pone.0026237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198388</ArticleId><ArticleId IdType="pubmed">22039449</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Fu C, Wu S, Chen X, Shi Y, Zhou B, et al. A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes. 2014;48(2):260–72. https://doi.org/10.1007/s11262-014-1035-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24442718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Wu X, Huang K, Li L, Zheng L, Wan C, et al. The variations of VP1 protein. might be associated with nervous system symptoms caused by enterovirus 71 infection. BMC Infect Dis. 2014;14:243. https://doi.org/10.1186/1471-2334-14-243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4101859</ArticleId><ArticleId IdType="pubmed">24886383</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SC, Li WC, Chen GW, Tsao KC, Huang CG, Huang YC, et al. Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes. J Med Virol. 2012;84(6):931–9. https://doi.org/10.1002/jmv.23287.</Citation><ArticleIdList><ArticleId IdType="pubmed">22499017</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen TY, Shih WL, Huang YC, Lee JT, Huang LM, Chang LY. Polymorphisms in enterovirus 71 receptors associated with susceptibility and clinical severity. PLoS One. 2018;13(11):e0206769. https://doi.org/10.1371/journal.pone.0206769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6218064</ArticleId><ArticleId IdType="pubmed">30395634</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Li Y, Yang Y, Peng C, Fu X, Gu X, et al. Virological investigation of genetic. variation of enterovirus type 71 in hand, foot and mouth disease. Exp Ther Med. 2020 Jul;20(1):543–9. https://doi.org/10.3892/etm.2020.8728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281934</ArticleId><ArticleId IdType="pubmed">32537012</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97–8. https://doi.org/10.1038/sj.cr.7290272.</Citation><ArticleIdList><ArticleId IdType="pubmed">15740637</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M, Wang X, Wang Q, Wang Y, Lin J, Sun Y, et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5(9):692–703. https://doi.org/10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Dong W, Quan X, Ma C, Qin C, Zhang L. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch Virol. 2012;157(3):539–43. https://doi.org/10.1007/s00705-011-1198-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">22187102</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugert P, Vosberg M, Entelmann M, Jahn J, Katus HA, Klüter H. Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease. Clin Chem Lab Med. 2004;42(9):997–1004. https://doi.org/10.1515/CCLM.2004.202.</Citation><ArticleIdList><ArticleId IdType="pubmed">15497463</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, Shimizu H, Ami Y, Tano Y, Harashima A, Suzaki Y, et al. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol. 2002;67(2):207–16. https://doi.org/10.1002/jmv.2209.</Citation><ArticleIdList><ArticleId IdType="pubmed">11992581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Badmanathan M, Devi S, Leong KL, Cardosa MJ, Wong KT. Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J Neuropathol Exp Neurol. 2008;67(6):532–42. https://doi.org/10.1097/NEN.0b013e31817713e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18520772</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, Iwasaki T, Ami Y, Tano Y, Harashima A, Suzaki Y, et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol. 2004;85(Pt 10):2981–9. https://doi.org/10.1099/vir.0.79883-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798–801. https://doi.org/10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr C. What are 3’ UTRs doing? Cold Spring Harb Perspect Biol. 2019;11(10):a034728. https://doi.org/10.1101/cshperspect.a034728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771366</ArticleId><ArticleId IdType="pubmed">30181377</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>